Superior Studios Fund I, LP is a newly formed Delaware venture capital fund seeking $10 million, and its September 29, 2026 SEC Form D shows that the vehicle was still at the starting line when the notice was filed. The issuer was formed in 2026, selected Rule 506(b) and the Section 3(c)(1) private-fund exclusion, reported zero investors and zero dollars sold, and stated that its first sale had yet to occur. The filing identifies 215 W. Superior Street, Suite 4 in Chicago as its principal place of business and names Brandon Cruz as an executive officer, director and promoter. These details establish a real exempt-offering filing, but they should not be confused with an SEC review or approval of Superior Studios, the fund's strategy or its expected returns; the SEC filing itself expressly warns readers that the Commission has not necessarily reviewed the information for accuracy or completeness.
Unlike some newly filed venture funds whose public footprint ends at EDGAR, Superior Studios already has an identifiable operating brand and investment activity outside the Form D. Its official website describes a pre-seed and seed strategy spanning areas including health, infrastructure, vertical AI and enterprise technology, and its published portfolio lists companies including Bridgeline AI, Nara, Perspectives Health, Prizm, Scaylor and Siftree. Independent financing coverage also identifies Superior Studios as an investor in Nara Health alongside Khosla Ventures and Long Journey Ventures, providing an external confirmation that the Superior Studios name has already appeared in an actual venture financing rather than existing only as a newly registered fund. That distinction materially improves transparency, although investors should still determine whether earlier Superior Studios investments were made personally, through another entity or directly through Fund I, because a portfolio displayed by the management brand does not automatically prove that every investment belongs to this specific limited partnership.
The strongest individual verification trail is Brandon Cruz. GoHealth's own SEC-filed 2026 proxy statement identifies Brandon M. Cruz as a co-founder of GoHealth and co-chairman of its board, states that he served as president from the company's founding in 2001 through 2020, and records later roles including Chief Strategy Officer and Special Advisor. Superior Studios-related public profiles separately identify Cruz as its founder and managing partner, creating a coherent career transition from operating a technology and insurance business into early-stage investing. This is substantially more verifiable than a fund whose manager has no independent corporate record, but investors should still distinguish Cruz's personal operating history from the performance history of Superior Studios Fund I: experience building or governing another company does not by itself establish the investment performance, valuation discipline or realized returns of a newly launched venture fund.
Two parts of the Form D deserve closer scrutiny because they could easily be misunderstood when viewed without context. First, Superior Studios reports a minimum investment of only $1. That is unusually low for a conventional venture capital partnership, but the Form D field alone does not establish that members of the public can invest one dollar in the fund; actual eligibility, subscription minimums, accredited-investor requirements and the GP's discretion should be checked against the confidential offering documents. Second, the governance chain is more layered than the fund name suggests. The filing names Superior Studios Fund I GP, LP as a related person, while Cruz signs not simply as the manager of the issuer's GP but specifically as "Manager of the GP of the GP of the Issuer." That wording indicates another general-partner layer above the named GP partnership, making the organizational chart, ownership, control rights and conflicts provisions worth obtaining directly from the partnership documents. The same filing reports no sales commissions or finder's fees and separately states that the general partner is entitled to carried interest under the confidential offering materials, so the economics cannot be understood merely from the $0 related-person proceeds field.
From a scam-risk perspective, Superior Studios Fund I presents considerably more independently checkable substance than a private fund supported only by a Form D and a newly created website. There is a real SEC filing, a functioning Superior Studios website, a published portfolio, evidence of participation in an outside financing round, a Chicago operating presence and a named manager whose GoHealth history can be verified directly through SEC public-company filings. The unresolved questions are instead fund-specific: Fund I itself is new, had raised no capital from any investor as of the filing, its reported $1 minimum requires explanation, and its layered GP structure means investors should determine exactly which entity controls the partnership and receives carried interest. Before transferring funds, a prospective limited partner should therefore obtain the private placement or offering materials, limited partnership agreement, subscription agreement, complete GP ownership chart, capital-call instructions, administrator and auditor information where applicable, banking or custody details, management-fee and carried-interest provisions, and confirmation of which published Superior Studios portfolio investments are actually attributable to Fund I. The public record does not provide evidence that Superior Studios Fund I is a scam, but the existence of strong founder credentials and a real investment platform should not replace fund-level due diligence on a vehicle that had not completed its first sale when the SEC notice was filed.